These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6090310)

  • 1. The acquisition of anti-influenza virus activity by macrophages.
    Mak NK; Ada GL
    Immunobiology; 1984 May; 166(4-5):458-72. PubMed ID: 6090310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The generation of 'cytotoxic' macrophages in mice during infection with influenza A or Sendai virus.
    Mak NK; Leung KN; Ada GL
    Scand J Immunol; 1982 Jun; 15(6):553-61. PubMed ID: 6181555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of virus specific cytotoxic T cells in vitro. III. Spleen cells stimulated by viral antigens generate alloreactive cytotoxic T cells.
    Koszinowski U; Greber D; Neuschaefer-Rube I
    Immunobiology; 1979 Aug; 156(1-2):83-95. PubMed ID: 232074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated cytotoxicity against Sendai-virus-infected cells.
    Ertl H; Koszinowski U
    Z Immunitatsforsch Immunobiol; 1976 Sep; 152(2):128-40. PubMed ID: 60844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor target-derived soluble factor synergizes with IFN-gamma and IL-2 to activate macrophages for tumor necrosis factor and nitric oxide production to mediate cytotoxicity of the same target.
    Jiang H; Stewart CA; Fast DJ; Leu RW
    J Immunol; 1992 Sep; 149(6):2137-46. PubMed ID: 1517576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage-mediated natural cytotoxicity of dimethyl sulfoxide-treated Friend erythroleukemia cells.
    Hsu KH; Friedman H
    J Natl Cancer Inst; 1985 Jul; 75(1):105-10. PubMed ID: 3859684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly I:C activated macrophages are tumoricidal for TNF-alpha-resistant 3LL tumor cells.
    Remels L; Fransen L; Huygen K; De Baetselier P
    J Immunol; 1990 Jun; 144(11):4477-86. PubMed ID: 2111350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of virus-specific cytotoxic T cells in vitro. II. Induction requirements with functionally inactivated virus preparations.
    Koszinowski UH; Gething MJ
    Eur J Immunol; 1980 Jan; 10(1):30-5. PubMed ID: 6244963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cell stimulatory factor-1 (interleukin 4) activates macrophages for increased tumoricidal activity and expression of Ia antigens.
    Crawford RM; Finbloom DS; Ohara J; Paul WE; Meltzer MS
    J Immunol; 1987 Jul; 139(1):135-41. PubMed ID: 3108395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and antigenic requirements for induction of T helper cells for anti-Sendai virus-specific antibody production.
    Ertl HC
    Eur J Immunol; 1981 Jul; 11(7):541-5. PubMed ID: 6269861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virion antigens introduced exogeneously into the cell membrane render syngeneic target cells susceptible for T cell-mediated cytolysis.
    Pfizenmaier K; Starzinski-Powitz A; Wagner H; Röllinghoff M
    Z Immunitatsforsch Immunobiol; 1977 Sep; 153(3):268-73. PubMed ID: 201114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sendai virus-specific T cell clones II. Induction of interferon production by Sendai virus-specific T helper cell clones.
    Ertl HC; Brown EG; Finberg RW
    Eur J Immunol; 1982 Dec; 12(12):1051-3. PubMed ID: 6297920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Virus infection activates IL-1 beta and IL-18 production in human macrophages by a caspase-1-dependent pathway.
    Pirhonen J; Sareneva T; Kurimoto M; Julkunen I; Matikainen S
    J Immunol; 1999 Jun; 162(12):7322-9. PubMed ID: 10358182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The inductive requirements for the primary in vitro generation of delayed-type hypersensitivity response to influenza virus in mice.
    Leung KN; Mak NK; Ada GL
    Immunology; 1981 Sep; 44(1):17-28. PubMed ID: 6792057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophage activation for tumor cytotoxicity: induction of macrophage tumoricidal activity by lymphokines from EL-4, a continuous T cell line.
    Meltzer MS; Benjamin WR; Farrar JJ
    J Immunol; 1982 Dec; 129(6):2802-7. PubMed ID: 6982943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-gamma differentially modulates the susceptibility of L1210 and P815 tumor targets for macrophage-mediated cytotoxicity. Role of macrophage-target interaction coupled to nitric oxide generation, but independent of tumor necrosis factor production.
    Leu RW; Leu NR; Shannon BJ; Fast DJ
    J Immunol; 1991 Sep; 147(6):1816-22. PubMed ID: 1909732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific immune lysis of paramyxovirus-infected cells by H-2-compatible thymus-derived lymphocytes.
    Doherty PC; Zinkernagel RM
    Immunology; 1976 Jul; 31(1):27-32. PubMed ID: 194830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus specificity of human influenza virus-immune cytotoxic T cells.
    Biddison WE; Shaw S; Nelson DL
    J Immunol; 1979 Feb; 122(2):660-4. PubMed ID: 84032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High strength binding of P815 mastocytoma cells is not necessary for their lysis by macrophages which have been primed and triggered in vitro.
    Lu CY; Lombardi MJ; Shea CM; Dustin LB
    J Immunol; 1988 Aug; 141(4):1083-90. PubMed ID: 3135320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.